Mark Levisson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mark Levisson has a total of 93 co-authors. Here are the top co-authors by number of shared publications:
- Servé W. M. Kengen
Laboratory of Microbiology, Wageningen University and Research, Wageningen, the Netherlands
11 shared publications John van der Oost
Laboratory of Microbiology, Department of Agrotechnology and Food, Wageningen University & Research, Wageningen, The Netherlands
10 shared publications- John van der Oost
Laboratory of Microbiology, Wageningen University & Research, Wageningen, Netherlands
5 shared publications - Hauke Smidt
Laboratory of Microbiology, Wageningen University & Research
4 shared publications - Jules Beekwilder
Wageningen Plant Research, Wageningen, The Netherlands
3 shared publications - Ruud A. Weusthuis
Bioprocess Engineering, Wageningen University and Research
3 shared publications
Latest Publications
- 21 October 2024
- Published by Wageningen University and Research
Biochemical and structural analysis of thermostable esterases
- 21 October 2024
- Published by Wageningen University and Research
Biochemical and structural analysis of thermostable esterases
- 1 August 2020
- Published by Elsevier in Trends in Biotechnology
- Vol. 38 (8) , 917-934
Plant Aromatic Prenyltransferases: Tools for Microbial Cell Factories
- 1 August 2020
- Published by Elsevier in Trends in Biotechnology
- Vol. 38 (8) , 917-934
Plant Aromatic Prenyltransferases: Tools for Microbial Cell Factories
- 1 November 2019
- Published by Elsevier in Biotechnology Advances
- Vol. 37 (7) , 107407
Microbial production of short and medium chain esters: Enzymes, pathways, and applications
- 1 November 2019
- Published by Elsevier in Biotechnology Advances
- Vol. 37 (7) , 107407
Microbial production of short and medium chain esters: Enzymes, pathways, and applications
- Open Access
- 24 April 2019
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 67 (49) , 13478-13486
Toward Developing a Yeast Cell Factory for the Production of Prenylated Flavonoids
Prenylated flavonoids possess a wide variety of biological activities, including estrogenic, antioxidant, antimicrobial and anticancer activity. Hence, they have potential applications in food products, medicines or supplements with health-promoting activities. However, the low abundance of prenylated flavonoids in nature is limiting their exploitation. Therefore, we investigated the prospect of producing prenylated flavonoids in the yeast Saccharomyces cerevisiae. As a proof of concept, we focused on the production of the potent phytoestrogen 8-prenylnaringenin. Introduction of the flavonoid prenyltransferase SfFPT from Sophora flavescens in naringenin-producing yeast strains resulted in de novo production of 8-prenylnaringenin. We generated several strains with increased production of the intermediate precursor naringenin, which finally resulted in a production of 0.12 mg L-1 (0.35 µM) of 8-prenylnaringenin under shake flask conditions. A number of bottlenecks in prenylated flavonoid production were identified and are discussed.
- 24 April 2019
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 67 (49) , 13478-13486
Open AccessToward Developing a Yeast Cell Factory for the Production of Prenylated Flavonoids
Prenylated flavonoids possess a wide variety of biological activities, including estrogenic, antioxidant, antimicrobial and anticancer activity. Hence, they have potential applications in food products, medicines or supplements with health-promoting activities. However, the low abundance of prenylated flavonoids in nature is limiting their exploitation. Therefore, we investigated the prospect of producing prenylated flavonoids in the yeast Saccharomyces cerevisiae. As a proof of concept, we focused on the production of the potent phytoestrogen 8-prenylnaringenin. Introduction of the flavonoid prenyltransferase SfFPT from Sophora flavescens in naringenin-producing yeast strains resulted in de novo production of 8-prenylnaringenin. We generated several strains with increased production of the intermediate precursor naringenin, which finally resulted in a production of 0.12 mg L-1 (0.35 µM) of 8-prenylnaringenin under shake flask conditions. A number of bottlenecks in prenylated flavonoid production were identified and are discussed.
- Open Access
- 3 July 2018
- Published by Springer Nature in Microbial Cell Factories
- Vol. 17 (1) , 1-16
Engineering de novo anthocyanin production in Saccharomyces cerevisiae
Anthocyanins are polyphenolic pigments which provide pink to blue colours in fruits and flowers. There is an increasing demand for anthocyanins, as food colorants and as health-promoting substances. Plant production of anthocyanins is often seasonal and cannot always meet demand due to low productivity and the complexity of the plant extracts. Therefore, a system of on-demand supply is useful. While a number of other (simpler) plant polyphenols have been successfully produced in the yeast Saccharomyces cerevisiae, production of anthocyanins has not yet been reported. Saccharomyces cerevisiae was engineered to produce pelargonidin 3-O-glucoside starting from glucose. Specific anthocyanin biosynthetic genes from Arabidopsis thaliana and Gerbera hybrida were introduced in a S. cerevisiae strain producing naringenin, the flavonoid precursor of anthocyanins. Upon culturing, pelargonidin and its 3-O-glucoside were detected inside the yeast cells, albeit at low concentrations. A number of related intermediates and side-products were much more abundant and were secreted into the culture medium. To optimize titers of pelargonidin 3-O-glucoside further, biosynthetic genes were stably integrated into the yeast genome, and formation of a major side-product, phloretic acid, was prevented by engineering the yeast chassis. Further engineering, by removing two glucosidases which are known to degrade pelargonidin 3-O-glucoside, did not result in higher yields of glycosylated pelargonidin. In aerated, pH controlled batch reactors, intracellular pelargonidin accumulation reached 0.01 µmol/gCDW, while kaempferol and dihydrokaempferol were effectively exported to reach extracellular concentration of 20 µM [5 mg/L] and 150 µM [44 mg/L], respectively. The results reported in this study demonstrate the proof-of-concept that S. cerevisiae is capable of de novo production of the anthocyanin pelargonidin 3-O-glucoside. Furthermore, while current conversion efficiencies are low, a number of clear bottlenecks have already been identified which, when overcome, have huge potential to enhance anthocyanin production efficiency. These results bode very well for the development of fermentation-based production systems for specific and individual anthocyanin molecules. Such systems have both great scientific value for identifying and characterising anthocyanin decorating enzymes as well as significant commercial potential for the production of, on-demand, pure bioactive compounds to be used in the food, health and even pharma industries.
- 3 July 2018
- Published by Springer Nature in Microbial Cell Factories
- Vol. 17 (1) , 1-16
Open AccessEngineering de novo anthocyanin production in Saccharomyces cerevisiae
Anthocyanins are polyphenolic pigments which provide pink to blue colours in fruits and flowers. There is an increasing demand for anthocyanins, as food colorants and as health-promoting substances. Plant production of anthocyanins is often seasonal and cannot always meet demand due to low productivity and the complexity of the plant extracts. Therefore, a system of on-demand supply is useful. While a number of other (simpler) plant polyphenols have been successfully produced in the yeast Saccharomyces cerevisiae, production of anthocyanins has not yet been reported. Saccharomyces cerevisiae was engineered to produce pelargonidin 3-O-glucoside starting from glucose. Specific anthocyanin biosynthetic genes from Arabidopsis thaliana and Gerbera hybrida were introduced in a S. cerevisiae strain producing naringenin, the flavonoid precursor of anthocyanins. Upon culturing, pelargonidin and its 3-O-glucoside were detected inside the yeast cells, albeit at low concentrations. A number of related intermediates and side-products were much more abundant and were secreted into the culture medium. To optimize titers of pelargonidin 3-O-glucoside further, biosynthetic genes were stably integrated into the yeast genome, and formation of a major side-product, phloretic acid, was prevented by engineering the yeast chassis. Further engineering, by removing two glucosidases which are known to degrade pelargonidin 3-O-glucoside, did not result in higher yields of glycosylated pelargonidin. In aerated, pH controlled batch reactors, intracellular pelargonidin accumulation reached 0.01 µmol/gCDW, while kaempferol and dihydrokaempferol were effectively exported to reach extracellular concentration of 20 µM [5 mg/L] and 150 µM [44 mg/L], respectively. The results reported in this study demonstrate the proof-of-concept that S. cerevisiae is capable of de novo production of the anthocyanin pelargonidin 3-O-glucoside. Furthermore, while current conversion efficiencies are low, a number of clear bottlenecks have already been identified which, when overcome, have huge potential to enhance anthocyanin production efficiency. These results bode very well for the development of fermentation-based production systems for specific and individual anthocyanin molecules. Such systems have both great scientific value for identifying and characterising anthocyanin decorating enzymes as well as significant commercial potential for the production of, on-demand, pure bioactive compounds to be used in the food, health and even pharma industries.
- 1 July 2017
- Published by Elsevier in Metabolic Engineering
- Vol. 42, 66-73
Monascus ruber as cell factory for lactic acid production at low pH
- 1 July 2017
- Published by Elsevier in Metabolic Engineering
- Vol. 42, 66-73
Monascus ruber as cell factory for lactic acid production at low pH
- 1 May 2017
- Published by Elsevier in Metabolic Engineering
- Vol. 41, 92-101
Ethyl acetate production by the elusive alcohol acetyltransferase from yeast
- 1 May 2017
- Published by Elsevier in Metabolic Engineering
- Vol. 41, 92-101
Ethyl acetate production by the elusive alcohol acetyltransferase from yeast
- Open Access
- 10 May 2016
- Published by Springer Nature in Scientific Reports
- Vol. 6 (1) , 25542
Structural and biochemical characterisation of Archaeoglobus fulgidus esterase reveals a bound CoA molecule in the vicinity of the active site
A new carboxyl esterase, AF-Est2, from the hyperthermophilic archaeon Archaeoglobus fulgidus has been cloned, over-expressed in Escherichia coli and biochemically and structurally characterized. The enzyme has high activity towards short- to medium-chain p-nitrophenyl carboxylic esters with optimal activity towards the valerate ester. The AF-Est2 has good solvent and pH stability and is very thermostable, showing no loss of activity after incubation for 30 min at 80 °C. The 1.4 Å resolution crystal structure of AF-Est2 reveals Coenzyme A (CoA) bound in the vicinity of the active site. Despite the presence of CoA bound to the AF-Est2 this enzyme has no CoA thioesterase activity. The pantetheine group of CoA partially obstructs the active site alcohol pocket suggesting that this ligand has a role in regulation of the enzyme activity. A comparison with closely related α/β hydrolase fold enzyme structures shows that the AF-Est2 has unique structural features that allow CoA binding. A comparison of the structure of AF-Est2 with the human carboxyl esterase 1, which has CoA thioesterase activity, reveals that CoA is bound to different parts of the core domain in these two enzymes and approaches the active site from opposite directions.
- 10 May 2016
- Published by Springer Nature in Scientific Reports
- Vol. 6 (1) , 25542
Open AccessStructural and biochemical characterisation of Archaeoglobus fulgidus esterase reveals a bound CoA molecule in the vicinity of the active site
A new carboxyl esterase, AF-Est2, from the hyperthermophilic archaeon Archaeoglobus fulgidus has been cloned, over-expressed in Escherichia coli and biochemically and structurally characterized. The enzyme has high activity towards short- to medium-chain p-nitrophenyl carboxylic esters with optimal activity towards the valerate ester. The AF-Est2 has good solvent and pH stability and is very thermostable, showing no loss of activity after incubation for 30 min at 80 °C. The 1.4 Å resolution crystal structure of AF-Est2 reveals Coenzyme A (CoA) bound in the vicinity of the active site. Despite the presence of CoA bound to the AF-Est2 this enzyme has no CoA thioesterase activity. The pantetheine group of CoA partially obstructs the active site alcohol pocket suggesting that this ligand has a role in regulation of the enzyme activity. A comparison with closely related α/β hydrolase fold enzyme structures shows that the AF-Est2 has unique structural features that allow CoA binding. A comparison of the structure of AF-Est2 with the human carboxyl esterase 1, which has CoA thioesterase activity, reveals that CoA is bound to different parts of the core domain in these two enzymes and approaches the active site from opposite directions.
- Open Access
- 5 July 2014
- Published by Wiley in Microbial Biotechnology
- Vol. 7 (5) , 456-466
vanI : a novel d ‐ A la‐ d ‐ L ac vancomycin resistance gene cluster found in D esulfitobacterium hafniense
Summary: The glycopeptide vancomycin was until recently considered a drug of last resort against Gram‐positive bacteria. Increasing numbers of bacteria, however, are found to carry genes that confer resistance to this antibiotic. So far, 10 different vancomycin resistance clusters have been described. A chromosomal vancomycin resistance gene cluster was previously described for the anaerobic D esulfitobacterium hafniense Y 51. We demonstrate that this gene cluster, characterized by its d ‐ A la‐ d ‐ L ac ligase‐encoding vanI gene, is present in all strains of D . hafniense , D . chlororespirans and some strains of D esulfosporosinus spp. This gene cluster was not found in vancomycin‐sensitive D esulfitobacterium or D esulfosporosinus spp., and we show that this antibiotic resistance can be exploited as an intrinsic selection marker for D esulfitobacterium hafniense and D . chlororespirans . The gene cluster containing vanI is phylogenetically only distantly related with those described from soil and gut bacteria, but clusters instead with vancomycin resistance genes found within the phylum A ctinobacteria that include several vancomycin‐producing bacteria. It lacks a vanH homologue, encoding a D ‐lactate dehydrogenase, previously thought to always be present within vancomycin resistance gene clusters. The location of vanH outside the resistance gene cluster likely hinders horizontal gene transfer. Hence, the vancomycin resistance cluster in D . hafniense should be regarded a novel one that we here designated vanI after its unique d ‐ A la‐ d ‐ L ac ligase.
- 5 July 2014
- Published by Wiley in Microbial Biotechnology
- Vol. 7 (5) , 456-466
Open AccessvanI : a novel d ‐ A la‐ d ‐ L ac vancomycin resistance gene cluster found in D esulfitobacterium hafniense
Summary: The glycopeptide vancomycin was until recently considered a drug of last resort against Gram‐positive bacteria. Increasing numbers of bacteria, however, are found to carry genes that confer resistance to this antibiotic. So far, 10 different vancomycin resistance clusters have been described. A chromosomal vancomycin resistance gene cluster was previously described for the anaerobic D esulfitobacterium hafniense Y 51. We demonstrate that this gene cluster, characterized by its d ‐ A la‐ d ‐ L ac ligase‐encoding vanI gene, is present in all strains of D . hafniense , D . chlororespirans and some strains of D esulfosporosinus spp. This gene cluster was not found in vancomycin‐sensitive D esulfitobacterium or D esulfosporosinus spp., and we show that this antibiotic resistance can be exploited as an intrinsic selection marker for D esulfitobacterium hafniense and D . chlororespirans . The gene cluster containing vanI is phylogenetically only distantly related with those described from soil and gut bacteria, but clusters instead with vancomycin resistance genes found within the phylum A ctinobacteria that include several vancomycin‐producing bacteria. It lacks a vanH homologue, encoding a D ‐lactate dehydrogenase, previously thought to always be present within vancomycin resistance gene clusters. The location of vanH outside the resistance gene cluster likely hinders horizontal gene transfer. Hence, the vancomycin resistance cluster in D . hafniense should be regarded a novel one that we here designated vanI after its unique d ‐ A la‐ d ‐ L ac ligase.
- Open Access
- 15 March 2014
- Published by American Society for Microbiology in Applied and Environmental Microbiology
- Vol. 80 (6) , 2011-2020
Molecular Characterization of an NADPH-Dependent Acetoin Reductase/2,3-Butanediol Dehydrogenase from Clostridium beijerinckii NCIMB 8052
Acetoin reductase is an important enzyme for the fermentative production of 2,3-butanediol, a chemical compound with a very broad industrial use. Here, we report on the discovery and characterization of an acetoin reductase from Clostridium beijerinckii NCIMB 8052. An in silico screen of the C. beijerinckii genome revealed eight potential acetoin reductases. One of them ( CBEI_1464 ) showed substantial acetoin reductase activity after expression in Escherichia coli . The purified enzyme ( C. beijerinckii acetoin reductase [Cb-ACR]) was found to exist predominantly as a homodimer. In addition to acetoin (or 2,3-butanediol), other secondary alcohols and corresponding ketones were converted as well, provided that another electronegative group was attached to the adjacent C-3 carbon. Optimal activity was at pH 6.5 (reduction) and 9.5 (oxidation) and around 68°C. Cb-ACR accepts both NADH and NADPH as electron donors; however, unlike closely related enzymes, NADPH is preferred ( K m , 32 μM). Cb-ACR was compared to characterized close homologs, all belonging to the “threonine dehydrogenase and related Zn-dependent dehydrogenases” (COG1063). Metal analysis confirmed the presence of 2 Zn 2+ atoms. To gain insight into the substrate and cofactor specificity, a structural model was constructed. The catalytic zinc atom is likely coordinated by Cys 37 , His 70 , and Glu 71 , while the structural zinc site is probably composed of Cys 100 , Cys 103 , Cys 106 , and Cys 114 . Residues determining NADP specificity were predicted as well. The physiological role of Cb-ACR in C. beijerinckii is discussed.
- 15 March 2014
- Published by American Society for Microbiology in Applied and Environmental Microbiology
- Vol. 80 (6) , 2011-2020
Open AccessMolecular Characterization of an NADPH-Dependent Acetoin Reductase/2,3-Butanediol Dehydrogenase from Clostridium beijerinckii NCIMB 8052
Acetoin reductase is an important enzyme for the fermentative production of 2,3-butanediol, a chemical compound with a very broad industrial use. Here, we report on the discovery and characterization of an acetoin reductase from Clostridium beijerinckii NCIMB 8052. An in silico screen of the C. beijerinckii genome revealed eight potential acetoin reductases. One of them ( CBEI_1464 ) showed substantial acetoin reductase activity after expression in Escherichia coli . The purified enzyme ( C. beijerinckii acetoin reductase [Cb-ACR]) was found to exist predominantly as a homodimer. In addition to acetoin (or 2,3-butanediol), other secondary alcohols and corresponding ketones were converted as well, provided that another electronegative group was attached to the adjacent C-3 carbon. Optimal activity was at pH 6.5 (reduction) and 9.5 (oxidation) and around 68°C. Cb-ACR accepts both NADH and NADPH as electron donors; however, unlike closely related enzymes, NADPH is preferred ( K m , 32 μM). Cb-ACR was compared to characterized close homologs, all belonging to the “threonine dehydrogenase and related Zn-dependent dehydrogenases” (COG1063). Metal analysis confirmed the presence of 2 Zn 2+ atoms. To gain insight into the substrate and cofactor specificity, a structural model was constructed. The catalytic zinc atom is likely coordinated by Cys 37 , His 70 , and Glu 71 , while the structural zinc site is probably composed of Cys 100 , Cys 103 , Cys 106 , and Cys 114 . Residues determining NADP specificity were predicted as well. The physiological role of Cb-ACR in C. beijerinckii is discussed.